
### [MONDO:0017034](http://purl.obolibrary.org/obo/MONDO_0017034)
**Label:** secondary interstitial lung disease in childhood and adulthood

**Subclasses:** [MONDO:0017039](http://purl.obolibrary.org/obo/MONDO_0017039) (drug or radiation exposure-related interstitial lung disease), [MONDO:0017853](http://purl.obolibrary.org/obo/MONDO_0017853) (hypersensitivity pneumonitis), [MONDO:0017038](http://purl.obolibrary.org/obo/MONDO_0017038) (secondary interstitial lung disease in childhood and adulthood associated with a systemic vasculitis), [MONDO:0017035](http://purl.obolibrary.org/obo/MONDO_0017035) (secondary interstitial lung disease in childhood and adulthood associated with a systemic disease), [MONDO:0017037](http://purl.obolibrary.org/obo/MONDO_0017037) (secondary interstitial lung disease in childhood and adulthood associated with a metabolic disease), [MONDO:0017036](http://purl.obolibrary.org/obo/MONDO_0017036) (Langerhans cell histiocytosis in childhood and adulthood), [MONDO:0018982](http://purl.obolibrary.org/obo/MONDO_0018982) (Niemann-Pick disease type C), [MONDO:0015492](http://purl.obolibrary.org/obo/MONDO_0015492) (Anti-neutrophil cytoplasmic antibody-associated vasculitis), [MONDO:0018483](http://purl.obolibrary.org/obo/MONDO_0018483) (secondary pulmonary alveolar proteinosis), [MONDO:0009757](http://purl.obolibrary.org/obo/MONDO_0009757) (Niemann-Pick disease, type C1), [MONDO:0007407](http://purl.obolibrary.org/obo/MONDO_0007407) (Cryoglobulinemic vasculitis), [MONDO:0012105](http://purl.obolibrary.org/obo/MONDO_0012105) (Wegener's granulomatosis), [MONDO:0016309](http://purl.obolibrary.org/obo/MONDO_0016309) (Niemann-Pick disease type C, juvenile neurologic onset), [MONDO:0011873](http://purl.obolibrary.org/obo/MONDO_0011873) (Niemann-Pick disease, type C2), [MONDO:0016306](http://purl.obolibrary.org/obo/MONDO_0016306) (Niemann-Pick disease type C, severe perinatal form), [MONDO:0016308](http://purl.obolibrary.org/obo/MONDO_0016308) (Niemann-Pick disease type C, late infantile neurologic onset), [MONDO:0016307](http://purl.obolibrary.org/obo/MONDO_0016307) (Niemann-Pick disease type C, severe early infantile neurologic onset), [MONDO:0020537](http://purl.obolibrary.org/obo/MONDO_0020537) (occupational allergic alveolitis), [MONDO:0020517](http://purl.obolibrary.org/obo/MONDO_0020517) (eosinophilic granuloma), [MONDO:0020519](http://purl.obolibrary.org/obo/MONDO_0020519) (hand-SchC<ller-Christian disease), [MONDO:0009265](http://purl.obolibrary.org/obo/MONDO_0009265) (Gaucher's disease type I), [MONDO:0019124](http://purl.obolibrary.org/obo/MONDO_0019124) (microscopic polyangiitis), [MONDO:0016310](http://purl.obolibrary.org/obo/MONDO_0016310) (Niemann-Pick disease type C, adult neurologic onset), [MONDO:0009303](http://purl.obolibrary.org/obo/MONDO_0009303) (anti-glomerular basement membrane disease), [MONDO:0020553](http://purl.obolibrary.org/obo/MONDO_0020553) (secondary pulmonary hemosiderosis), [MONDO:0020554](http://purl.obolibrary.org/obo/MONDO_0020554) (Heiner syndrome), [MONDO:0017040](http://purl.obolibrary.org/obo/MONDO_0017040) (exposure-related interstitial lung disease), [MONDO:0020535](http://purl.obolibrary.org/obo/MONDO_0020535) (house allergic alveolitis), [MONDO:0020536](http://purl.obolibrary.org/obo/MONDO_0020536) (pigeon-breeder lung disease), [MONDO:0005854](http://purl.obolibrary.org/obo/MONDO_0005854) (mixed connective tissue disease), [MONDO:0001971](http://purl.obolibrary.org/obo/MONDO_0001971) (farmer's lung disease), [MONDO:0007776](http://purl.obolibrary.org/obo/MONDO_0007776) (hypersensitivity pneumonitis, familial), [MONDO:0015928](http://purl.obolibrary.org/obo/MONDO_0015928) (secondary interstitial lung disease in childhood and adulthood associated with a connective tissue disease), [MONDO:0015943](http://purl.obolibrary.org/obo/MONDO_0015943) (eosinophilic granulomatosis with polyangiitis), [MONDO:0019726](http://purl.obolibrary.org/obo/MONDO_0019726) (type II mixed cryoglobulinemia), [MONDO:0019727](http://purl.obolibrary.org/obo/MONDO_0019727) (mixed cryoglobulinemia type III), 

**Mapped go classes:** [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0006680](http://purl.obolibrary.org/obo/GO_0006680) (glucosylceramide catabolic process), [GO:0006486](http://purl.obolibrary.org/obo/GO_0006486) (protein glycosylation), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:1904457](http://purl.obolibrary.org/obo/GO_1904457) (positive regulation of neuronal action potential), [GO:0043589](http://purl.obolibrary.org/obo/GO_0043589) (skin morphogenesis), [GO:0051246](http://purl.obolibrary.org/obo/GO_0051246) (regulation of protein metabolic process), [GO:0051247](http://purl.obolibrary.org/obo/GO_0051247) (positive regulation of protein metabolic process), [GO:0023021](http://purl.obolibrary.org/obo/GO_0023021) (termination of signal transduction), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0032366](http://purl.obolibrary.org/obo/GO_0032366) (intracellular sterol transport), [GO:0032367](http://purl.obolibrary.org/obo/GO_0032367) (intracellular cholesterol transport), [GO:0033574](http://purl.obolibrary.org/obo/GO_0033574) (response to testosterone), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:1903052](http://purl.obolibrary.org/obo/GO_1903052) (positive regulation of proteolysis involved in cellular protein catabolic process), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:1905037](http://purl.obolibrary.org/obo/GO_1905037) (autophagosome organization), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0006897](http://purl.obolibrary.org/obo/GO_0006897) (endocytosis), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0046624](http://purl.obolibrary.org/obo/GO_0046624) (sphingolipid transporter activity), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0004348](http://purl.obolibrary.org/obo/GO_0004348) (glucosylceramidase activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0016242](http://purl.obolibrary.org/obo/GO_0016242) (negative regulation of macroautophagy), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0071404](http://purl.obolibrary.org/obo/GO_0071404) (cellular response to low-density lipoprotein particle stimulus), [GO:0046718](http://purl.obolibrary.org/obo/GO_0046718) (viral entry into host cell), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0033561](http://purl.obolibrary.org/obo/GO_0033561) (regulation of water loss via skin), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0046512](http://purl.obolibrary.org/obo/GO_0046512) (sphingosine biosynthetic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0043243](http://purl.obolibrary.org/obo/GO_0043243) (positive regulation of protein complex disassembly), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0043202](http://purl.obolibrary.org/obo/GO_0043202) (lysosomal lumen), [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0090150](http://purl.obolibrary.org/obo/GO_0090150) (establishment of protein localization to membrane), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0007628](http://purl.obolibrary.org/obo/GO_0007628) (adult walking behavior), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0097066](http://purl.obolibrary.org/obo/GO_0097066) (response to thyroid hormone), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0035855](http://purl.obolibrary.org/obo/GO_0035855) (megakaryocyte development), [GO:0032268](http://purl.obolibrary.org/obo/GO_0032268) (regulation of cellular protein metabolic process), [GO:0032463](http://purl.obolibrary.org/obo/GO_0032463) (negative regulation of protein homooligomerization), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:1903061](http://purl.obolibrary.org/obo/GO_1903061) (positive regulation of protein lipidation), [GO:0031579](http://purl.obolibrary.org/obo/GO_0031579) (membrane raft organization), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:0036268](http://purl.obolibrary.org/obo/GO_0036268) (swimming), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0000328](http://purl.obolibrary.org/obo/GO_0000328) (fungal-type vacuole lumen), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0046686](http://purl.obolibrary.org/obo/GO_0046686) (response to cadmium ion), [GO:0009268](http://purl.obolibrary.org/obo/GO_0009268) (response to pH), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0000324](http://purl.obolibrary.org/obo/GO_0000324) (fungal-type vacuole), [GO:1904925](http://purl.obolibrary.org/obo/GO_1904925) (positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0071383](http://purl.obolibrary.org/obo/GO_0071383) (cellular response to steroid hormone stimulus), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0070050](http://purl.obolibrary.org/obo/GO_0070050) (neuron cellular homeostasis), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:1901805](http://purl.obolibrary.org/obo/GO_1901805) (beta-glucoside catabolic process), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0055113](http://purl.obolibrary.org/obo/GO_0055113) (epiboly involved in gastrulation with mouth forming second), [GO:2000189](http://purl.obolibrary.org/obo/GO_2000189) (positive regulation of cholesterol homeostasis), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0071548](http://purl.obolibrary.org/obo/GO_0071548) (response to dexamethasone), 

**Class expressions from DL-Learner:**

- Thing 53.07%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 52.17%
- [GO:0005775](http://purl.obolibrary.org/obo/GO_0005775) (vacuolar lumen) 52.17%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 52.17%
- [GO:0000328](http://purl.obolibrary.org/obo/GO_0000328) (fungal-type vacuole lumen) 52.17%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.53%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.53%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005568](http://purl.obolibrary.org/obo/GO_0005568) (obsolete mitochondrial rRNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.53%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005567](http://purl.obolibrary.org/obo/GO_0005567) (obsolete cytosolic ribosomal RNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.53%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005566](http://purl.obolibrary.org/obo/GO_0005566) (obsolete ribosomal RNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.53%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005565](http://purl.obolibrary.org/obo/GO_0005565) (obsolete mitochondrial tRNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.53%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005564](http://purl.obolibrary.org/obo/GO_0005564) (obsolete cytosolic tRNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.53%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005563](http://purl.obolibrary.org/obo/GO_0005563) (obsolete transfer RNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.53%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005562](http://purl.obolibrary.org/obo/GO_0005562) (obsolete RNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.53%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005561](http://purl.obolibrary.org/obo/GO_0005561) (obsolete nucleic acid) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.53%


